DOI: 10.12890/2022_003314
Two Cases of BRASH Syndrome: A Diagnostic Challenge
Authors
yoshiton@hawaii.edu
Keywords
BRASH syndrome, bradycardia, renal failure, atrioventricular nodal blocker, shock, hyperkalemiaAbstract
Bradycardia, renal failure, atrioventricular (AV) nodal blockade, shock, and hyperkalemia (BRASH) syndrome is a relatively new clinical entity. It is often underrecognized, underdiagnosed, and confused with other causes of bradycardia. Treatment of BRASH syndrome differs from the standard bradycardia algorithm in advanced cardiac life support (ACLS), and the cornerstone management remains treating the hyperkalemia, improving renal function by treating the underlying cause, withholding AV nodal blocking agents, and considering dialysis in refractory cases, as any single factor could precipitate the vicious cycle. Here we describe two cases of BRASH syndrome with different clinical presentations that were treated with conservative management: one case in a 77-year-old Japanese woman and the other in an 86-year-old man.
References
- Farkas JD, Long B, Koyfman A, Menson K. BRASH syndrome: bradycardia, renal failure, AV blockade, shock, and hyperkalemia. J Emerg Med 2020;59(2):216–223.
- Grautoff S, Holtz L. Hyperkalemia and BRASH syndrome in emergency medicine: clinical significance and association with ECG findings. Notf Rett Med 2020;23(3):172–179.
- Arif AW, Khan MS, Masri A, Mba B, Talha Ayub M, Doukky R. BRASH syndrome with hyperkalemia: an under-recognized clinical condition. Methodist Debakey Cardiovasc J 2020;163):241–244.
- Srivastava S, Kemnic T, Hildebrandt KR. BRASH syndrome. BMJ Case Rep 2020;13(2):e233825.
- Grigorov MV, Belur AD, Otero D, Chaudhary S, Grigorov E, Ghafghazi S. The BRASH syndrome, a synergistic arrhythmia phenomenon. Proc (Bayl Univ Med Cent) 2020;33(4):668–670.